$MLAB Cashflow Statement | Understand Stock

$MLAB

$131.32 +$2.07 (1.6%) Close

$MLAB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Depreciation of property, plant and equipment
Amortization of acquisition-related intangibles
Stock-based compensation expense
Non-cash interest expense and debt issuance cost amortization
Gain on extinguishment of convertible senior notes
Amortization of step-up in inventory basis
Deferred taxes
Impairment loss on goodwill and finite-lived intangible assets
Other

Cash from changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued liabilities and taxes payable
Unearned revenues
Net cash provided by operating activities
Cash flows from investing activities:
Acquisitions, net of cash acquired
Purchases of property, plant and equipment
Proceeds from the sale of assets
Acquisition of customer lists
Acquisition of businesses, net of cash acquired and holdback liabilities
Net cash (used in) investing activities

Cash flows from financing activities:
Proceeds from the issuance of convertible senior notes, net
Proceeds from debt borrowings
Repurchase of convertible note debt
Other debt principal repayments
GKE acquisition holdback payment
Dividends paid
Payment of tax withholding obligation on vesting of restricted stock
Payment of debt issuance costs
Proceeds from the exercise of stock options
Other financing, net
Net cash (used in) provided by financing activities
Net (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Effect of exchange rate changes on cash and cash equivalents
Cash paid for:
Income taxes
Interest
New acquisition-related consideration held back against potential indemnification losses
Contingent consideration from new acquisitions

Comments